Shares of Envision Healthcare Holdings dropped more than 5 percent following news of its merger with AmSurg.
Running a medical device business requires understanding of the medical technology as well as the corporate environment, Uscom CEO Rob Phillips says.
Walgreens says it will close all 40 Theranos Wellness Centers and will no longer offer any Theranos services at any of its stores.
The net worth of Theranos founder and chief executive has dwindled to zero, according to Forbes Magazine.
J&J's consumer brands and medical devices units are poised for growth following turnaround efforts, CEO Alex Gorsky says.
A London start-up has invented a do-it-yourself DNA kit consumers can use to test the "athlete gene" — and other genetic identity markers.
A huge Hewlett Packard Enterprise project hopes to use massive data sets to better craft medical treatments and medicines for patients.
Scientists are one step closer in harnessing the power of genome sequencing to help improve the diagnosis and treatment of autism.
Elizabeth Holmes tells NBC's 'Today' Show that she wishes the company's issues were caught sooner.
NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.
With a grant from the Defense Department, a Florida medical center is creating a video game to train doctors for robotic surgery.
It's hoped the FDA will approve an artificial pancreas in 2017. The device is expected to transform treatment of type 1 diabetes.
In an interview with CNBC, the NIH director said people may be "a little cynical" because of cancer's casualty rate, but researchers 'had its number.'
Mount Sinai Hospital's CEO told CNBC that while Obamacare survived a repeal attempt, it's locked in a tough game of numbers.
Peloton Cycle CEO John Foley explains how the company behind indoor cycling technology is experiencing massive growth.
New advances provide new hope for prosthetics, including an accurate sense of touch and robotic limbs developed at a fraction of the cost.
Before testing your own genome, it helps to realize it can raise more questions than it answers.
A $199 service from health company 23andMe gives individuals data from ancestry to risks of carrying a genetic condition.
Personalized medicine is more costly than traditional treatment, which worries insurers. But these drugs can improve outcomes for patients.
Surgeons use 3-D printed replica of patients' brains to improve surgery performance.